Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-02-23

FDA Approved: CUVPOSA — Supplemental Application (Merz Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for CUVPOSA (glycopyrrolate) by Merz Pharmaceuticals, LLC. The action updates the product's labeling under an approved s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CUVPOSA (glycopyrrolate)

Snippet

SUPPL AP for CUVPOSA (GLYCOPYRROLATE)